NIFTY
54.90  0.50%
 10961.85
S&P BSE SENSEX
192.35  0.53%
 36578.96
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 21-Jan-2019
NSE
6.15    0.8%
Rs. 776.20
 
Days Low
Rs. 768.95
Days High
Rs. 784.5

Open Rs. 769.8
 
52 week Low
Rs. 527.05
52 week High
Rs.830
 
 
Bid :                 0.00 (0)
Offer :        776.00 (25)
BSE
Rs.776.00
5.45    0.71%
on 21-Jan-2019
BSE
5.45    0.71%
Rs. 776.00
 
Days Low
Rs. 767.2
Days High
Rs. 784.8

Open Rs. 770.4
 
52 week Low
Rs. 527
52 week High
Rs.830.45
 
 
Bid :                 0.00 (0)
Offer :        776.00 (25)
NSE
Rs.776.20
6.15    0.8%
 
 
Last Price (Rs.)  776.00 Value  58913790.00
Net Change (Rs.)  5.45 Best Buy  0.00
Volume  75553 Best Sell  776.00
Prev.Close (Rs.)  770.55 Best Quantity  0
Open (Rs.)  769.80 Sell Quantity  25
High (Rs.)  784.50 52-Week High (Rs.)  830.00
Low (Rs.)  768.95 52-Week Low (Rs.)  527.05
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  454664.30
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Currents Investments0.20 0.20 0.20 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 398.35 955772 77.62 0.00 0.50
Dr. Reddys Lab 2601.85 432065 725.78 76.19 0.77
Piramal Enterprises 2281.70 418916 1080.13 79.33 1.10
Cipla 510.80 411535 183.33 28.00 0.59
Biocon 663.20 397920 117.12 166.84 0.15
 
Mutual Funds Holdings
Scheme Name% HoldNo.Shares
HDFC Balanced Advantage Fund(G) 1.63 8570828
HDFC Hybrid Equity Fund(G) 2.26 6761000
HDFC Equity Fund(G) 1.92 5457526
HDFC Top 100 Fund(G) 1.74 3632450
SBI BlueChip Fund-Reg(G) 1.24 3497861
 
Quarterly Result
(Rs .in millions)Sep 2018Jun 2018Mar 2018
Net Sales31703.9025588.2023547.20
Operating Profit6111.503995.804842.40
PBDT5803.503757.104668.30
Net Profit3809.502251.203082.90
More> 
 
Company News
1/18/2019 12:00:00 AM
Suyog Telematics, Sundram Fasteners and Aurobindo Pharma to see some a...
1/18/2019 12:00:00 AM
Aurobindo Pharma’s arm to acquire portfolio of seven marketed oncology...
1/18/2019 12:00:00 AM
Aurobindo Pharma gains on the bourses
More>
 
Ratios
   Earnings Per Share (Rs)30.94 
   Book NAV/Share(Rs)170.38 
   PAT Margin (%)17.59 
   Asset Turnover(x)0.71 
   PER(x)18.01 
   Yield(%)0.45 
   EV/Core EBITDA(x)13.13 
   M Cap / Sales3.18 
   Net Sales Growth(%)6.90 
   PAT Growth(%)6.21 
   Total Debt/Equity(x)0.37 
   Current Ratio(x)1.56 
   Quick Ratio(x)0.97 
   Total Debt/Mcap(x)0.11 
More>